Article
Houston-based Texas Children’s Hospital has opened a new pediatric stone clinic to provide comprehensive care for children and adolescents with kidney stones.
Houston-based Texas Children’s Hospital has opened a new pediatric stone clinic to provide comprehensive care for children and adolescents with kidney stones.
Separately, the hospital announced the addition of three new physicians to its pediatric urology team.
The new stone clinic will be comprised of a multidisciplinary team of specialists who evaluate, diagnose, and treat children who have previously had kidney stones, as well as those who are at risk for developing them.
“In children with kidney stones, there can be underlying metabolic, genetic or anatomic causes,” said Dr. Nicolette Janzen, MD, of Texas Children’s and Baylor College of Medicine. “That is why we recognized the need and importance of opening a specialized clinic for the children affected by this condition.”
The clinic will bring together clinicians from three subspecialties: pediatric urologists, pediatric nephrologists, and a registered renal dietitian, all of whom will evaluate patients with urinary tract stones in a single visit.
In related news, three new physicians have joined Texas Children’s Hospital’s urology division: Chester Koh, MD, Bruce Schlomer, MD, and Abhishek Seth, MD.
“I am thrilled to welcome these three new physicians to our team. In addition to being able to provide more convenient access to patients, their arrival will allow us to expand our research, helping to bring new treatments and techniques to the bedside, and provide minimally invasive surgery options through the acquisition of a da Vinci Si Surgical System manned by an expert in the field,” said David Roth, MD, chief of pediatric urology at Texas Children’s Hospital.
Dr. Koh is an internationally recognized expert in robotic surgery and minimally invasive surgery in children. He has been instrumental in developing cutting-edge techniques with both the laparoscope and the da Vinci robot. Dr. Koh spent the past 8 years at Children’s Hospital Los Angeles/USC.
Dr. Schlomer has an interest in disorders of sex development such as congenital adrenal hyperplasia and will work in Texas Children’s Gender Medicine Clinic. He completed a 2-year fellowship at the University of California, San Francisco, where he spent a year focused on outcomes research.
Dr. Seth completed his 3-year fellowship at Boston Children’s Hospital/Harvard Medical School, where he spent 2 years in the basic science lab focusing on bladder regeneration and neurogenic bladder. He will continue his research on the epigenetics of bladder inflammation and will provide clinical support for many urologic disorders, including neurogenic bladder.
FDA approves oral sulopenem for uncomplicated urinary tract infection
FDA approves IDE for study evaluating underactive bladder device
IC/BPS has more than 1 phenotype: A need for consensus to move forward